| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 50, 226-229, Copyright © 1980 by Endocrine Society
ARTICLES |
JS Sawers, AD Toft, WJ Irvine, NS Brown and J Seth
Thirty consecutive patients with thyrotoxicosis were followed up at monthly intervals for 6 months after treatment with iodine-131. Serum total T4, serum total T3, and serum TSH response to TRH were measured at each review. Biochemical evidence of hypothyroidism (low T4 raised basal TSH) developed in 18 patients 1-4 months after treatment. In 5 of these patients, symptoms and signs of hypothyroidism remained absent or minimal and spontaneous recovery of thyroid function occurred during the ensuing 2 months. If biochemical hypothyroidism occurs during the first 6 months after radioiodine therapy, it is recommended that T4 replacement be withheld for 2 months unless the severity of symptoms demands treatment.
This article has been cited by other articles:
![]() |
E. K. Alexander and P. R. Larsen American Board of Internal Medicine. 2002 Certification Examination in Endocrinology, Diabetes, and Metabolism J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1073 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Toft Thyroxine Therapy N. Engl. J. Med., July 21, 1994; 331(3): 174 - 180. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |